Cellink AB is trading at 1.98 as of the 17th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.98. Cellink AB has more than 69 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of November 2025 and ending today, the 17th of February 2026. Click here to learn more.
BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States. The company has 69.07 M outstanding shares. More on Cellink AB
Cellink AB [CLLKF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 657.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cellink AB's market, we take the total number of its shares issued and multiply it by Cellink AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cellink AB classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 69.07 M outstanding shares.
Cellink AB generates negative cash flow from operations
Check Cellink AB Probability Of BankruptcyOwnership AllocationCellink AB holds a total of 69.07 Million outstanding shares. Cellink AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cellink Ownership Details
About 39.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.23. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellink AB had not issued any dividends in recent years. The entity had 4:1 split on the 10th of January 2020. BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.The quote for Cellink AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Cellink AB please contact Erik Gatenholm at 46 7 08 30 08 90 or go to https://www.bico.com.
Cellink AB Investment Alerts
Cellink AB generated a negative expected return over the last 90 days
Cellink AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 1.26 B. Net Loss for the year was (227.6 M) with profit before overhead, payroll, taxes, and interest of 1.03 B.
Cellink AB generates negative cash flow from operations
About 39.0% of the company shares are held by company insiders
Cellink Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 657.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cellink AB's market, we take the total number of its shares issued and multiply it by Cellink AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Cellink Profitablity
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average.
Technical Drivers
As of the 17th of February 2026, Cellink AB shows the Standard Deviation of 3.24, risk adjusted performance of (0.02), and Mean Deviation of 1.08. Cellink AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cellink ABstandard deviation and maximum drawdown to decide if Cellink AB is priced correctly, providing market reflects its regular price of 1.98 per share. Please also double-check Cellink AB jensen alpha, which is currently at (0.15) to validate the company can sustain itself at a future point.
The output start index for this execution was zero with a total number of output elements of sixty-one. Cellink AB Tanh Of Price Series is a hyperbolic price transformation function.
Cellink AB Predictive Daily Indicators
Cellink AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cellink AB pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cellink AB's time-series forecasting models are one of many Cellink AB's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cellink AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Cellink AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Valuation Now
Equity Valuation
Check real value of public entities based on technical and fundamental data
Other Information on Investing in Cellink Pink Sheet
Cellink AB financial ratios help investors to determine whether Cellink Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.